Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...

This is the first study to report the rotational stability of the AcrySof SA60TT toric IOL in a series of 44 cases 3 months after implantation in cataract surgery. In this series, the largest rotation ...

Please provide your email address to receive an email when new articles are posted on . FORT WORTH, Texas — A toric IOL for use in cataract patients with existing astigmatism has been granted U.S.

To compare AcrySof toric intraocular lens (IOL) and non-toric IOL in patients who had combined 23-gauge microincisional vitrectomy surgery (MIVS) and phacoemulsification for vitreoretinal diseases and ...

BASEL, Switzerland, January 26, 2017 - Alcon, the global leader in eye care and a division of Novartis, announces the launch of AcrySof ® IQ PanOptix ® Toric presbyopia- and astigmatism-correcting ...

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...

Please provide your email address to receive an email when new articles are posted on . HUENENBERG, Switzerland — The Centers for Medicare and Medicaid Services has approved the inclusion of Alcon's ...

Two human cadaver eyes were prepared in accordance with the Miyake–Apple technique, with closed-system modification. After phacoemulsification, an Acrysof Toric IOL was implanted in the capsular bag.

PanOptix, the first and only advanced trifocal lens for U.S. patients undergoing cataract surgery, will be showcased in educational events and clinical data presentations First-ever analyses on IOLs ...

Forty-four eyes of 33 patients underwent routine phacoemulsification cataract surgery with in-the-bag implantation of a toric AcrySof IOLs. Seven eyes were implanted with the SA60T3 IOL, 17 eyes were ...

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...